Clinical trial NCT04379726 - References

Cystic Fibrosis-related Diabetes — β-cell Function and Insulin Sensitivity in Patients With Cystic Fibrosis

Citation(s)

•   Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D
  Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care. 2008 Sep;31(9):1789-94. doi: 10.2337/dc08-0466. Epub 2008
•   Ali BR
  Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells? Med Hypotheses. 2009 Jan;72(1):55-7. doi: 10.1016/j.mehy.2008.07.058. Epub 2008 Oct 11.
•   Association AD
  1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020 Jan;43(Suppl 1):S7-S13. doi: 10.2337/dc20-S001. Review.
•   Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S
  Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab. 1994 Jul;79(1):80-5.
•   Blackman SM, Commander CW, Watson C, Arcara KM, Strug LJ, Stonebraker JR, Wright FA, Rommens JM, Sun L, Pace RG, Norris SA, Durie PR, Drumm ML, Knowles MR, Cutting GR
  Genetic modifiers of cystic fibrosis-related diabetes. Diabetes. 2013 Oct;62(10):3627-3
•   Blackman SM, Tangpricha V
  Endocrine Disorders in Cystic Fibrosis. Pediatr Clin North Am. 2016 Aug;63(4):699-708. doi: 10.1016/j.pcl.2016.04.009. Review.
•   Bonadonna RC, Heise T, Arbet-Engels C, Kapitza C, Avogaro A, Grimsby J, Zhi J, Grippo JF, Balena R
  Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients wi
•   Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R
  Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrin
•   Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD
  Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child. 2002 Nov;87(5):430-1.
•   Edlund A, Esguerra JL, Wendt A, Flodström-Tullberg M, Eliasson L
  CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells. BMC Med. 2014 May 28;12:87. doi: 10.1186/1741-7015-12-87
•   Edlund A, Pedersen MG, Lindqvist A, Wierup N, Flodström-Tullberg M, Eliasson L
  CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells. Sci Rep. 2017 Mar 7;7(1):90. doi: 10.1038/s41598-017-00098-8.
•   Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Howenstine M, McColley SA, Rock M, Rosenfeld M, Sermet-Gaudelus I, Southern KW, Marshall BC, Sosnay PR
  Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundatio
•   Grancini V, Trombetta M, Lunati ME, Zimbalatti D, Boselli ML, Gatti S, Donato MF, Resi V, D'Ambrosio R, Aghemo A, Pugliese G, Bonadonna RC, Orsi E
  Contribution of ß-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severit
•   Guo JH, Chen H, Ruan YC, Zhang XL, Zhang XH, Fok KL, Tsang LL, Yu MK, Huang WQ, Sun X, Chung YW, Jiang X, Sohma Y, Chan HC
  Glucose-induced electrical activities and insulin secretion in pancreatic islet ß-cells are modulated by CFTR. Nat Commun. 2014 Jul
•   Haardt M, Benharouga M, Lechardeur D, Kartner N, Lukacs GL
  C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation. J Biol Chem. 1999 Jul 30;274(31):21873-7.
•   Hudson VM
  Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med. 2001 Jun 15;30(12):1440-61. Review.
•   Kelly A, Moran A
  Update on cystic fibrosis-related diabetes. J Cyst Fibros. 2013 Jul;12(4):318-31. doi: 10.1016/j.jcf.2013.02.008. Epub 2013 Apr 3. Review. Erratum in: J Cyst Fibros. 2014 Jan;13(1):119.
•   Koivula FNM, McClenaghan NH, Harper AGS, Kelly C
  Islet-intrinsic effects of CFTR mutation. Diabetologia. 2016 Jul;59(7):1350-1355. doi: 10.1007/s00125-016-3936-1. Epub 2016 Mar 31. Review. Erratum in: Diabetologia. 2017 Dec;60(12):2544.
•   Lanng S, Thorsteinsson B, Røder ME, Nerup J, Koch C
  Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol (Oxf). 1994 Aug;41(2):217-23.
•   Lewis C, Blackman SM, Nelson A, Oberdorfer E, Wells D, Dunitz J, Thomas W, Moran A
  Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex. Am J Respir Crit Care Med. 2015 Jan 15;191(2):194-200. doi: 10.1164/rccm.201403-0576OC
•   MacKenzie T, Gifford AH, Sabadosa KA, Quinton HB, Knapp EA, Goss CH, Marshall BC
  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med. 2014 Aug 19;161(
•   Mari A, Camastra S, Toschi E, Giancaterini A, Gastaldelli A, Mingrone G, Ferrannini E
  A model for glucose control of insulin secretion during 24 h of free living. Diabetes. 2001 Feb;50 Suppl 1:S164-8.
•   Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ
  A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001 Mar;24(3):539-48. Erratum in: Diabetes Care. 2014 Jul;37(7):2063.
•   Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ
  Epidemiology of cystic fibrosis-related diabetes. J Pediatr. 2005 May;146(5):681-7.
•   Milla CE, Warwick WJ, Moran A
  Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):891-5.
•   Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B; CFRD Guidelines Committee
  Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Associatio
•   Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP
  Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991 May;118(5):715-23.
•   Moran A, Doherty L, Wang X, Thomas W
  Abnormal glucose metabolism in cystic fibrosis. J Pediatr. 1998 Jul;133(1):10-17. Review.
•   Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W
  Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009 Sep;32(9):1626-31. doi: 10.2337/dc09-0586. Epub 2009 Jun 19.
•   Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H; Cystic Fibrosis Related Diabetes Therapy Study Group
  Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cy
•   Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER
  Insulin sensitivity in cystic fibrosis. Diabetes. 1994 Aug;43(8):1020-6.
•   Mozzillo E, Franzese A, Valerio G, Sepe A, De Simone I, Mazzarella G, Ferri P, Raia V
  One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements. Pediatr Diabetes. 20
•   Ntimbane T, Comte B, Mailhot G, Berthiaume Y, Poitout V, Prentki M, Rabasa-Lhoret R, Levy E
  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev. 2009 Nov;30(4):153-77.
•   Ode KL, Moran A
  New insights into cystic fibrosis-related diabetes in children. Lancet Diabetes Endocrinol. 2013 Sep;1(1):52-8. doi: 10.1016/S2213-8587(13)70015-9. Epub 2013 May 23. Review.
•   Rowe SM, Miller S, Sorscher EJ
  Cystic fibrosis. N Engl J Med. 2005 May 12;352(19):1992-2001.
•   Schaedel C, de Monestrol I, Hjelte L, Johannesson M, Kornfält R, Lindblad A, Strandvik B, Wahlgren L, Holmberg L
  Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol. 2002 Jun;33(6):483-91.
•   Sheikh S, Gudipaty L, De Leon DD, Hadjiliadis D, Kubrak C, Rosenfeld NK, Nyirjesy SC, Peleckis AJ, Malik S, Stefanovski D, Cuchel M, Rubenstein RC, Kelly A, Rickels MR
  Reduced ß-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Suffi
•   Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S; European Cystic Fibrosis Society
  European Cystic Fibrosis Society Standards of Care
•   Sun X, Yi Y, Xie W, Liang B, Winter MC, He N, Liu X, Luo M, Yang Y, Ode KL, Uc A, Norris AW, Engelhardt JF
  CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors. Endocrinology. 2017 Oct 1;158(10):33
•   Yoon JC
  Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes. J Endocr Soc. 2017 Oct 30;1(11):1386-1400. doi: 10.1210/js.2017-00362. eCollection 2017 Nov 1. Review.

Characterization of β-cell Function and Insulin Sensitivity in Pre-transplant Patients With Cystic Fibrosis

Details for clinical trial NCT04379726